Activation of Protease-Activated Receptor-1 Causes Chronic Pain in Lupus-Prone Mice Via Suppressing Spinal Glial Glutamate Transporter Function and Enhancing Glutamatergic Synaptic Activity

J Pain. 2023 Jul;24(7):1163-1180. doi: 10.1016/j.jpain.2023.01.003. Epub 2023 Jan 11.

Abstract

Systemic lupus erythematosus (SLE) is an unpredictable autoimmune disease where the body's immune system mistakenly attacks healthy tissues in many parts of the body. Chronic pain is one of the most frequently reported symptoms among SLE patients. We previously reported that MRL lupus prone (MRL/lpr) mice develop hypersensitivity to mechanical and heat stimulation. In the present study, we found that the spinal protease-activated receptor-1(PAR1) plays an important role in the genesis of chronic pain in MRL/lpr mice. Female MRL/lpr mice with chronic pain had activation of astrocytes, over-expression of thrombin and PAR1, enhanced glutamatergic synaptic activity, as well as suppressed activity of adenosine monophosphate-activated protein kinase (AMPK) and glial glutamate transport function in the spinal cord. Intrathecal injection of either the PAR1 antagonist, or AMPK activator attenuated heat hyperalgesia and mechanical allodynia in MRL/lpr mice. Furthermore, we also identified that the enhanced glutamatergic synaptic activity and suppressed activity of glial glutamate transporters in the spinal dorsal horn of MRL/lpr mice are caused by activation of the PAR1 and suppression of AMPK signaling pathways. These findings suggest that targeting the PAR1 and AMPK signaling pathways in the spinal cord may be a useful approach for treating chronic pain caused by SLE. PERSPECTIVE: Our study provides evidence suggesting activation of PAR1 and suppression of AMPK in the spinal cord induces thermal hyperalgesia and mechanical allodynia in a lupus mouse model. Targeting signaling pathways regulating the PAR1 and AMPK could potentially provide a novel approach to the management of chronic pain caused by SLE.

Keywords: Glutamate uptake; MRL lupus-prone; Neuroinflammation; Nociception; Protease-activated receptor-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Amino Acid Transport System X-AG / metabolism
  • Animals
  • Chronic Pain* / etiology
  • Chronic Pain* / metabolism
  • Female
  • Glutamates / metabolism
  • Hyperalgesia / etiology
  • Hyperalgesia / metabolism
  • Lupus Erythematosus, Systemic* / metabolism
  • Mice
  • Receptor, PAR-1 / metabolism
  • Spinal Cord Dorsal Horn / metabolism

Substances

  • Receptor, PAR-1
  • AMP-Activated Protein Kinases
  • Amino Acid Transport System X-AG
  • Glutamates